Placental and Cord Blood Markers Associated With Premature Birth and Disorders of Premature Birth in Newborn Infants

Completed

Conditions studied: Premature Birth

In brief

The purpose of this study is to determine if changes in specific gene products in the placenta or cord/infant blood affect a baby's birth weight, increase the risk of premature birth, or increase the risk of developing diseases of prematurity. We would also like to characterize whether placental epigenetic changes or placental markers of environmental exposures are associated with premature birth.

Key facts

Study ID

NCT01439048

Run by

Medical College of Wisconsin

People needed

82

Starts

2009-06-01

Expected to finish

2015-08-01

Last updated by the study team

2015-08-28

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• all infants born alive

You may not qualify if…

• infants who are born with no signs of life

Where it is running

• Froedtert Memorial Lutheran Hospital — Wauwatosa, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.